BD Medical, a segment of BD (Becton, Dickinson and Company), has announced the UK launch of the latest BD Nexiva™ Closed IV Catheter System designed to reduce healthcare workers’ risk of needlestick injuries and minimise exposure to blood. The system includes the BD Q-SyteTM Luer Access Split Septum to help reduce catheter-related bloodstream infections (CRBSIs).
The latest version of the BD Nexiva™ system introduces key developments, including a new non-removable pinch clamp for easy, one-handed activation and soft stabilisation platform designed to decrease catheter movement and associated complications, whilst providing greater patient comfort. The new catheter grip design also accommodates the various insertion techniques employed by clinicians.
Suzanne Grant, business director at BD Medical, said: “The latest BD Nexiva™ Closed IV Catheter System reflects our ongoing efforts to improve clinical efficacy and patient comfort in infusion therapy — it not only simplifies the IV therapy process, but also is designed to remove some typical sources of risk.”
Studies have shown that needlestick injuries are a significant risk to the physical and psychological health of nurses, and cause significant additional costs to healthcare provision .
Used for peripheral venous access, the all-in-one BD NexivaTM system is designed to reduce insertion attempts and limit healthcare workers’ exposure to blood with its innovative blood-containment system that helps minimise blood leakage from the catheter hub. This safety-engineered system is also designed to reduce needlestick injury by using passive needle-shielding technology that does not compromise the insertion techniques.
Studies in Europe have estimated that the associated costs of CRBSIs may be hundreds of millions of euros . An important feature incorporated into the BD Nexiva™ Closed IV Catheter System is the BD Q-SyteTM Luer Access Split Septum, which offers a straight and unobstructed fluid path, high flow rates, clear visibility and cleanability. A split septum needle access system has 64-70% lower CRBSI rates than mechanical valves. By eliminating the complexities of mechanical valves, this split-septum device helps reduce the number of places where bacteria may thrive. In fact, comparison studies found that patients are three times more likely, on average, to develop a CRBSI with mechanical valves versus a split-septum needle-less access system.
